2010;154C:46976
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management (under the brand name Ozempic) and chronic weight management (Wegovy)
MC2R: Reportedly located in the adrenal cortex, it is suggested that this receptor may play a role in the production of cortisol
Despite wide dose ranges tested (6 g/kg to 20 mg/kg), multiple administration routes (intramuscular, intraperitoneal, intravenous, oral), and varied dosing frequencies across numerous animal models, no acute lethal dose has been identified
This serum: contains glutathione for bright, radiant skin
Weight loss, especially if its paired with appetite changes from GLP-1s, can mean youre drinking less